СТАТИИ

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

Cardiac-resynchronization therapy (CRT) benefits patients with left ventricular systolic dysfunction and a wide QRS complex. Most of these patients are candidates for an implantable cardioverter–defibrillator (ICD). We evaluated whether adding CRT to an ICD and optimal medical therapy might reduce mortality and morbidity among such patients.

Линк към статията

РЕКЛАМА